GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share guidance of $4.25-4.35 for the period, compared to the consensus earnings per share estimate of $4.25. GE HealthCare Technologies also updated its FY 2024 guidance to 4.250-4.350 EPS.
GE HealthCare Technologies Trading Up 1.4 %
Shares of GE HealthCare Technologies stock traded up $1.23 during trading on Wednesday, hitting $86.50. The company's stock had a trading volume of 999,676 shares, compared to its average volume of 2,991,236. The stock has a market cap of $39.48 billion, a price-to-earnings ratio of 24.93, a price-to-earnings-growth ratio of 3.34 and a beta of 1.18. GE HealthCare Technologies has a 52 week low of $65.77 and a 52 week high of $94.55. The stock has a 50-day moving average price of $88.46 and a two-hundred day moving average price of $83.39. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.06 and a quick ratio of 0.82.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, topping analysts' consensus estimates of $0.98 by $0.02. The company had revenue of $4.84 billion for the quarter, compared to analyst estimates of $4.88 billion. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The firm's quarterly revenue was up .5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.92 earnings per share. Equities research analysts anticipate that GE HealthCare Technologies will post 4.26 EPS for the current fiscal year.
GE HealthCare Technologies Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a $0.03 dividend. The ex-dividend date is Friday, October 18th. This represents a $0.12 annualized dividend and a yield of 0.14%. GE HealthCare Technologies's payout ratio is 3.51%.
Wall Street Analysts Forecast Growth
Several equities research analysts recently commented on GEHC shares. BTIG Research upgraded GE HealthCare Technologies from a "neutral" rating to a "buy" rating and set a $100.00 target price on the stock in a research report on Wednesday, September 18th. Evercore ISI raised their price target on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an "outperform" rating in a report on Tuesday, October 1st. UBS Group lowered shares of GE HealthCare Technologies from a "neutral" rating to a "sell" rating and dropped their price objective for the company from $84.00 to $74.00 in a report on Thursday, September 26th. JPMorgan Chase & Co. started coverage on GE HealthCare Technologies in a research note on Monday, September 9th. They set a "neutral" rating and a $90.00 price target on the stock. Finally, Stifel Nicolaus raised their price objective on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a "buy" rating in a research note on Monday, September 30th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $94.23.
Check Out Our Latest Research Report on GEHC
Insider Activity
In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the business's stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total value of $222,145.00. Following the transaction, the chief executive officer now owns 17,509 shares of the company's stock, valued at approximately $1,414,377.02. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.27% of the stock is currently owned by corporate insiders.
GE HealthCare Technologies Company Profile
(
Get Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
